The systemic angiotensin-II role in the development of retinopathy of prematurity

QR Code

The systemic angiotensin-II role in the development of retinopathy of prematurity

Purpose: to determine the role of the systemic angiotensin II (AT-II) in the pathogenesis of retinopathy of prematurity (ROP) and assess its prognostic value.Material and methods. 34 premature infants at risk of developing ROP were examined according to the ophthalmological ROP screening protocol ad...

Full description

Saved in:

Bibliographic Details
Main Authors:	N. A. Osipova, N. B. Chesnokova, L. A. Katargina, T. A. Pavlenko, O. V. Beznos, A. Yu. Panova
Format:	Article
Language:	Russian
Published:	Real Time Ltd 2023-07-01
Series:	Российский офтальмологический журнал
Subjects:	retinopathy of prematurity pathogenesis screening, angiotensin renin-angiotensin system
Online Access:	https://roj.igb.ru/jour/article/view/1234
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Angiotensin-II as a Trigger Factor in the Development of Retinopathy of Prematurity
by: L. A. Katargina, et al.
Published: (2020-12-01)

Variation of Concentrations of Angiotensin II, AngiotensinConverting Enzyme and Matrix Metalloprotease-9 in Tears and Serum of Patients with Diabetic Retinopathy
by: V. V. Neroev, et al.
Published: (2020-12-01)

Angiotensins and rheumatoid arthritis
by: N. M. Savushkina, et al.
Published: (2019-01-01)

RENIN-ANGIOTENSIN SYSTEM IN REGULATION OF HEMATOPOIESIS
by: M. L. Kanaeva, et al.
Published: (2018-02-01)

The role of the classical renin–angiotensin system and angiotensin-converting enzyme 2/Ang(1–7)/Mas axis in pulmonary fibrosis
by: Changhui Lang, et al.
Published: (2025-07-01)

Angiogenic properties of catecholamines from the viewpoint of the pathogenesis of retinopathy of prematurity
by: L. A. Katargina, et al.
Published: (2018-12-01)

ANGIOTENSIN II RECEPTOR TYPE 1 EXPRESSION IN PATIENTS WITH MULTIFOCAL ATHEROSCLEROSIS
by: I. S. Mykhailichenko
Published: (2016-04-01)

Studying the pathogenic role of catecholamines in the development of retinopathy of prematurity on an experimental model of the disease
by: L. A. Katargina, et al.
Published: (2019-12-01)

LONG-TERM EFFECTS OF OLMESARTAN, AN ANG II RECEPTOR ANTAGONIST, ON BLOOD PRESSURE AND THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: Shuichi Ichikawa, et al.
Published: (2011-06-01)

Angiotensin II and Cardiovascular Disease: Balancing Pathogenic and Protective Pathways
by: Ulvi Bayraktutan
Published: (2025-07-01)

Left ventricular hypertrophy: renin4angiotensin system role
by: F. T. Ageev, et al.
Published: (2008-04-01)

ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASE: WHAT TO CHOOSE?
by: K. A. Ghyamdzhyan, et al.
Published: (2012-09-01)

The effect of renin-angiotensin system blockers on aldosterone levels in patients with chronic heart failure with preserved ejection fraction
by: A. N. Shevelok
Published: (2020-12-01)

Angiotensin Converting Enzyme Inhibitors: Interaction Issues in Patients with Glaucoma and Arterial Hypertension. Review
by: S. I. Makogon, et al.
Published: (2023-12-01)

Angiotensin II type 1 receptor antagonists and ACE inhibitors in the regulation of hemodynamics and renin-angiotensin-aldosterone system activity: focus on the organ protection
by: M. L. Maksimov, et al.
Published: (2010-04-01)

The frequency and clinical course of retinopathy of prematurity in modern developmental care conditions as evidenced by the Moscow region perinatal center
by: L. A. Katargina, et al.
Published: (2020-09-01)

View on the problem of diabetic nephropathy in children and adolescents with type 1 diabetes: the role of renin-angiotensin-aldosterone system (literature review) (part 2)
by: K. V. Skobeleva, et al.
Published: (2021-06-01)

View on the problem of diabetic nephropathy in children and adolescents with type 1 diabetes mellitus: the role of renin-angiotensin-aldosterone system (literature review) (part 1)
by: K. V. Skobeleva, et al.
Published: (2021-06-01)

Clinical Course and Results of Anti-VEGF Therapy of Retinopathy of Prematurity
by: L. A. Katargina, et al.
Published: (2021-04-01)

The Renin–Angiotensin System Modulates SARS-CoV-2 Entry via ACE2 Receptor
by: Sophia Gagliardi, et al.
Published: (2025-07-01)

An experimental Study of the Pathogenesis of Retinopathy of Prematurity as a Promising Direction of Search for New Medicinal Approaches to its Prevention and Treatment
by: L. A. Katargina, et al.
Published: (2018-10-01)

New opportunities in management of patients with retinopathy prematurity (literature review and analysis of own data)
by: L. A. Katargina, et al.
Published: (2020-12-01)

RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND REPLICATIVE CELLULAR SENESCENCE: THEIR INTERACTION DURING THE VASCULAR AGEING
by: V. S. Pykhtina, et al.
Published: (2015-09-01)

Angiotensin II and COVID-19. Secrets of interactions
by: A. O. Konradi, et al.
Published: (2020-05-01)

System of the ophthalmologic help premature children with retinopathy of prematurity in the Central region of Russia
by: A. V. Tereshchenko, et al.
Published: (2014-07-01)

Prospects of using genetic testing to increase the effectiveness of antihypertensive therapy
by: N. V. Drobotya, et al.
Published: (2020-06-01)

The modern view on the concept of treatment of active stages of retinopathy of prematurity
by: A. V. Tereshchenko, et al.
Published: (2014-07-01)

The functional state of the kallikrein-kinin and renin-angiotensin-aldosterone systems in patients with localized kidney cancer
by: N. D. Ushakova, et al.
Published: (2021-12-01)

INFLUENCE OF THE POLYMORPHISM OF THE RENIN-ANGIOTENSIN SYSTEM GENES ON THE CARDIAC ARRHYTHMIAS IN CHILDREN WITH HYPERTROPHIC CARDIOMYOPATHY
by: N. A. Berezneva, et al.
Published: (2013-05-01)

Pharmacogenetic aspects of eprosartan therapy and polymorphic markers of renin-angiotensin-aldosterone system genes in Uzbek patients with essential arterial hypertension
by: D. R. Kurbanova, et al.
Published: (2009-06-01)

Time of vitreal surgery for active retinopathy of prematurity
by: A. V. Tereshchenko, et al.
Published: (2021-12-01)

Association of insertion deletion polymorphism of the ACE gene with factors of circulating rennin-angiotensin-aldosterone system and endothelial function of skin microvassals in preeclampsia
by: O. V. Radkov, et al.
Published: (2011-08-01)

THE PREVENTION OF BLINDNESS AND VISUAL IMPAIRMENT IN CHILDREN WITH RETINOPATHY OF PREMATURITY
by: V. V. Neroev, et al.
Published: (2015-04-01)

Optimization of renin-angiotensin-aldosterone inhibitor therapies for evidence-based indications: A call to action from the cardio-kidney community
by: Roberto Pecoits-Filho, et al.
Published: (2025-09-01)

The Role of Retinopathy Anemia in the Pathogenesis of Retinopathy of Prematurity and the Effect of Erythropoietin Treatment on the Frequency and Severity of the Disease
by: V. I. Lebedev, et al.
Published: (2020-11-01)

ELABELA Ameliorates Atherosclerosis Through Restoring the M1/M2 Macrophage Balance in ApoE−/− Mice
by: Le Tang, et al.
Published: (2025-07-01)

Optimization of Renin-Angiotensin-Aldosterone Inhibitor Therapies for Evidence-Based Indications: a Call to Action From the Cardio-Kidney Community
by: Roberto Pecoits-Filho, MD, PhD, et al.
Published: (2025-07-01)

Retinopathy of Prematurity. Review
by: N. V. Popova, et al.
Published: (2021-10-01)

Heart and pulmonary artery remodeling association with various levels of natriuretic peptides and renin-angiotensin-aldosterone system activation in patients with pulmonary hypertension of various etiology
by: Yu. A. Andreeva, et al.
Published: (2008-12-01)

On the impact of seasonal solar activity on the progression of retinopathy of prematurity: preliminary research results
by: A. N. Epikhin, et al.
Published: (2019-12-01)